DALLAS, TX—Johnson & Johnson contributed to the all-in settlement deal struck last year that would resolve opioid lawsuits against the company. The additional commitment brings Johnson and Johnson up to $5 billion in total contributions. The settlement is part of the $48 billion frameworks that four states North Carolina, Tennessee, Texas, and Pennsylvania announced one year ago in which Johnson & Johnson and four other companies Cardinal Health, McKesson, AmerisourceBergen, and Teva agreed to provide $22 billion in cash. In addition, $26 billion worth of generic opioid addiction treatment, product distribution, and data tracking measures.
The settlement is an indication that numerous other lawsuits filed across the U.S. could be moving toward resolution, said Partner Matthew McCarley of Fears Nachawati Law Firm.